These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7513991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM.
    Cancer Res; 1998 Aug 15; 58(16):3719-26. PubMed ID: 9721884
    [Abstract] [Full Text] [Related]

  • 3. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
    Harn HJ, Ho LI, Yu CP, Wang MW, Lee HS, Lin JJ, Lee WH, Isola NR, Cooper DL.
    Biochem Mol Biol Int; 1994 Feb 15; 32(2):233-8. PubMed ID: 7517252
    [Abstract] [Full Text] [Related]

  • 4. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
    Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, Toge T, Tahara E, Tarin D.
    Cancer Res; 1995 Oct 01; 55(19):4273-7. PubMed ID: 7545538
    [Abstract] [Full Text] [Related]

  • 5. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I, Yajima A.
    Cancer Res; 1994 Jul 15; 54(14):3922-8. PubMed ID: 7518345
    [Abstract] [Full Text] [Related]

  • 6. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H.
    Gynecol Oncol; 1995 Jun 15; 57(3):383-7. PubMed ID: 7539775
    [Abstract] [Full Text] [Related]

  • 7. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF, Zhu D, Bourguignon LY.
    J Cell Physiol; 1995 Sep 15; 164(3):605-12. PubMed ID: 7544357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New CD44 splice variants associated with human breast cancers.
    Iida N, Bourguignon LY.
    J Cell Physiol; 1995 Jan 15; 162(1):127-33. PubMed ID: 7529235
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V, Kern HF, Elsässer HP.
    Clin Cancer Res; 1996 Sep 15; 2(9):1607-18. PubMed ID: 9816340
    [Abstract] [Full Text] [Related]

  • 11. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ, Lee HS, Ho LI, Lee WH, Ding JH.
    Biochem Mol Biol Int; 1994 Jul 15; 33(4):743-9. PubMed ID: 7526922
    [Abstract] [Full Text] [Related]

  • 12. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A, Gobl A, Eriksson B, Skogseid B, Oberg K.
    Cancer Res; 1994 Feb 15; 54(4):981-6. PubMed ID: 7508823
    [Abstract] [Full Text] [Related]

  • 13. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis.
    Givehchian M, Woerner SM, Lacroix J, Zöller M, Drings P, Becker H, Kayser K, Ridder R, von Knebel Doeberitz M.
    Oncogene; 1996 Mar 07; 12(5):1137-44. PubMed ID: 8649806
    [Abstract] [Full Text] [Related]

  • 14. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
    Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST.
    Cancer Res; 1993 Oct 15; 53(20):4754-6. PubMed ID: 7691404
    [Abstract] [Full Text] [Related]

  • 15. CD44 splice variants: expression during lymphocyte activation and tumor progression.
    Pals ST, Koopman G, Heider KH, Griffioen A, Adolf GR, Van den Berg F, Ponta H, Herrlich P, Horst E.
    Behring Inst Mitt; 1993 Aug 15; (92):273-7. PubMed ID: 7504454
    [Abstract] [Full Text] [Related]

  • 16. Trans-acting factors regulate the expression of CD44 splice variants.
    Konig H, Moll J, Ponta H, Herrlich P.
    EMBO J; 1996 Aug 01; 15(15):4030-9. PubMed ID: 8670907
    [Abstract] [Full Text] [Related]

  • 17. [Expression of CD44 alternative splicing variants in lung cancer].
    Ohgami A, Sugio K, Mitsudomi T, Tsuda T, Yasumoto K.
    Nihon Rinsho; 1995 Jul 01; 53(7):1704-9. PubMed ID: 7630011
    [Abstract] [Full Text] [Related]

  • 18. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
    Ermak G, Gerasimov G, Troshina K, Jennings T, Robinson L, Ross JS, Figge J.
    Cancer Res; 1995 Oct 15; 55(20):4594-8. PubMed ID: 7553635
    [Abstract] [Full Text] [Related]

  • 19. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
    Dall P, Heider KH, Hekele A, von Minckwitz G, Kaufmann M, Ponta H, Herrlich P.
    Cancer Res; 1994 Jul 01; 54(13):3337-41. PubMed ID: 7516819
    [Abstract] [Full Text] [Related]

  • 20. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
    Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U.
    Cancer Res; 1991 Oct 01; 51(19):5292-7. PubMed ID: 1717145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.